Clinical Lung Cancer

SJR Rank #2,898H-index: 83SJR: 1.362Best quartile: Q1APC: US$3,200
Journal website: aims, scope and author guidelines
Publisher

Elsevier Inc.

Country

United States

Type

journal

SJR by Edition

2022202500.350.71.051.4

Subject Categories

  • OncologyQ1
  • Pulmonary and Respiratory MedicineQ1
  • Cancer ResearchQ2

Areas: Biochemistry, Genetics and Molecular Biology · Medicine

Most published research topics

Lung Cancer Treatments and MutationsLung Cancer Diagnosis and TreatmentLung Cancer Research StudiesCancer Immunotherapy and BiomarkersRadiomics and Machine Learning in Medical ImagingDiverse Scientific and Economic StudiesCancer Genomics and DiagnosticsColorectal Cancer Treatments and StudiesHepatocellular Carcinoma Treatment and PrognosisNeuroendocrine Tumor Research Advances

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs0150300450600

Documents per Year

20222025050100150200

Detailed Information

ISSN

1938-0690, 1525-7304

SJR Best Quartile

Q1

Region

Northern America

Citations per Document (2 years)

3.63

References per Document

30.28

Coverage

2000-2026

Scope

Clinical Lung Cancer is a peer-reviewed bimonthly journal that publishes original articles describing various aspects of clinical and translational research of lung cancer. Clinical Lung Cancer is devoted to articles on detection, diagnosis, prevention, and treatment of lung cancer. The main emphasis is on recent scientific developments in all areas related to lung cancer. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.

Metrics from SCImago Journal Rank 2025. View on SCImago